Texas Yale Capital Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Texas Yale Capital Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$923K	Hold	7,225	–	–	0.03%	299
2025 Q4	$881K	Hold	7,225	–	–	0.03%	294
2025 Q3	$724K	Hold	7,225	–	–	0.02%	312
2025 Q2	$599K	Hold	7,225	–	–	0.02%	317
2025 Q1	$586K	Hold	7,225	–	–	0.02%	315
2024 Q4	$651K	Sell	7,225 -15	-0.2%	-$1.45K	0.03%	297
2024 Q3	$715K	Hold	7,240	–	–	0.03%	299
2024 Q2	$671K	Sell	7,240 -3,889	-35%	-$349K	0.03%	294
2024 Q1	$1.06M	Hold	11,129	–	–	0.05%	248
2023 Q4	$994K	Hold	11,129	–	–	0.05%	248
2023 Q3	$813K	Buy	11,129 +1,224	+12%	+$97.8K	0.04%	255
2023 Q2	$824K	Hold	9,905	–	–	0.04%	265
2023 Q1	$755K	Hold	9,905	–	–	0.04%	275
2022 Q4	$822K	Hold	9,905	–	–	0.05%	266
2022 Q3	$786K	Hold	9,905	–	–	0.05%	260
2022 Q2	$736K	Sell	9,905 -9,795	-50%	-$735K	0.05%	269
2022 Q1	$1.77M	Hold	19,700	–	–	0.1%	183
2021 Q4	$2.21M	Hold	19,700	–	–	0.11%	163
2021 Q3	$2.48M	Buy	19,700 +615	+3%	+$79.2K	0.14%	139
2021 Q2	$2.58M	Sell	19,085 -320	-2%	-$42.1K	0.15%	134
2021 Q1	$2.63M	Buy	19,405 +320	+2%	+$47.9K	0.17%	120
2020 Q4	$2.69M	Hold	19,085	–	–	0.18%	110
2020 Q3	$2.13M	Hold	19,085	–	–	0.16%	126
2020 Q2	$2.14M	Buy	19,085 +2,050	+12%	+$202K	0.17%	121
2020 Q1	$1.32M	Hold	17,035	–	–	0.13%	156
2019 Q4	$1.62M	Hold	17,035	–	–	0.11%	174
2019 Q3	$1.3M	Hold	17,035	–	–	0.09%	200
2019 Q2	$1.49M	Sell	17,035 -17,035	-50%	-$1.45M	0.11%	180
2019 Q1	$3.08M	Buy	34,070 +17,035	+100%	+$1.45M	0.12%	168
2018 Q4	$1.22M	Sell	17,035 -900	-5%	-$72.5K	0.11%	179
2018 Q3	$1.72M	Hold	17,935	–	–	0.14%	145
2018 Q2	$1.71M	Hold	17,935	–	–	0.15%	132
2018 Q1	$1.57M	Sell	17,935 -1,440	-7%	-$131K	0.14%	147
2017 Q4	$1.64M	Buy	19,375 +900	+5%	+$75.4K	0.14%	144
2017 Q3	$1.6M	Sell	18,475 -75	-0.4%	-$6.01K	0.14%	141
2017 Q2	$1.43M	Buy	+18,550	New	+$1.32M	0.13%	152
2015 Q3	–	Sell	-2,670	Closed	-$224K	–	490
2015 Q2	$224K	Hold	2,670	–	–	0.02%	445
2015 Q1	$201K	Buy	+2,670	New	+$187K	0.02%	459
2013 Q4	–	Sell	-4,965	Closed	-$214K	–	316
2013 Q3	$214K	Buy	+4,965	New	+$201K	0.04%	277

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Texas Yale Capital Corp's XBI Position: Q1 2026 in Review

Texas Yale Capital Corp held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 7,225 shares worth $923K. The position accounts for 0.03% of the portfolio, ranked #299.

Texas Yale Capital Corp first reported a position in XBI in Q3 2013 and has held it in 39 quarters since. The position peaked at $3.08M in Q1 2019. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Texas Yale Capital Corp held 7,225 shares of State Street SPDR S&P Biotech ETF worth $923K as of Q1 2026.
Texas Yale Capital Corp left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.03% of Texas Yale Capital Corp's portfolio in Q1 2026, its #299 holding.
Texas Yale Capital Corp first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 39 quarters since.
Texas Yale Capital Corp's State Street SPDR S&P Biotech ETF position peaked at $3.08M in Q1 2019.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.